IGFBP7 and gastric cancer: In the independent validation cohort, the serum IGFBP7 level in gastric cancer group was 1.592 ± 0.253 ng/ml, lower than in the normal control group (2.011 ± 0.563 ng/ml, p < 0.0001, Fig. 2B).